Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 08:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple

La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple ...
March 27, 2026 08:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma Recommendation based on positive results demonstrating...
March 27, 2026 05:30 ET | Source: SNS Insider pvt ltd

Pruritus Therapeutics Market Size is Projected to Reach USD 15.58 Billion by 2035 Due to the Increasing Cases of Chronic Inflammatory Skin Diseases Globally | SNS Insider

Pruritus therapeutics market to reach $15.58 Bn by 2035, driven by rising skin disorders, strong biologics pipeline, and expanding global treatment demand.
March 26, 2026 14:22 ET | Source: BCC Research LLC

Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment

The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.
March 26, 2026 08:00 ET | Source: Geron Corporation

Geron Announces Appointment of New Members to its Board of Directors

FOSTER CITY, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer,...
March 25, 2026 08:00 ET | Source: NodThera

NodThera to Participate in April Investor Conferences

BOSTON, March 25, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of best-in-class brain-penetrant and immune-targeted oral inhibitors to address...
March 24, 2026 07:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling

KØBENHAVN, Danmark, 24. marts 2026 – I overensstemmelse med vedtægternes §§ 10-14 indkaldes herved til ordinær generalforsamling i Bavarian Nordic A/S: Tirsdag den 21. april 2026 kl. 16.00 hos...
March 24, 2026 07:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S – Notice Convening Annual General Meeting

COPENHAGEN, Denmark, 24 March 2026 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on ...
March 24, 2026 02:30 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Mise en ligne du document «Q1 2026 aide-mémoire »

Mise en ligne du document «Q1 2026 aide-mémoire » Paris, France – 24 mars 2026. Sanofi annonce la mise en ligne de son « Q1 2026 aide-mémoire » sur la page « Investisseurs » de son site internet. ...
March 24, 2026 02:30 ET | Source: Sanofi Winthrop Industrie

Press release: Availability of the Q1 2026 aide-mémoire

Availability of the Q1 2026 aide-mémoire Paris, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aide-mémoire on the "Investors" page of the company's website: First...